Robert Andtbacka on Managing Side Effects From T-VEC

Video

Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.

Robert Andtbacka, MD, associate professor, Division of Surgical Oncology, Department of Surgery, University of Utah School of Medicine, discusses the management of side effects from T-VEC.

Rigors and chills are quite common, but can be managed fairly easily. If a patient experiences these side effects, Andtbacka says, a physician should premeditate him or her with Tylenol and antihistamines in future treatments. After 5-7 injections, the side effects usually go away completely.

Overall, T-VEC is very well tolerated and most patients can go to work and continue with other everyday activities.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Image of a woman with blond hair wearing a headset and a hospital badge over a blouse in front of a watercolor Oncology Nursing News background
© 2025 MJH Life Sciences

All rights reserved.